心房颤动患者CA-125表达水平及其意义

doi:10.3969/j.issn.2095-9400.2019.12.011

摘要
图/表
参考文献
相关文章 (1)

全文: PDF (1520 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：探讨CA-125在阵发性和持续性心房颤动（简称房颤）患者中的表达水平及其意义。方法：回顾性分析2017年6月至2018年6月在温州医科大学附属第一医院住院的642例房颤患者临床资料。将入组房颤患者根据阵发/持续房颤分为2组，比较临床资料（年龄、性别、BMI、房颤病程、左房内径、射血分数、BNP、肝肾功能、CHA2DS2-VASc评分、CA-125等），应用多因素logistic回归分析持续性房颤的危险因素。结果：与阵发性房颤患者相比，持续性房颤患者的CA-125水平更高（P＜0.001）。Logistic回归分析显示CA-125是持续性房颤的独立危险因素（P＜0.05）。结论：CA-125可能是持续性房颤的预测指标。

	服务
	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	陈晨
	胡晓康
	王恺婧
	黄周青

关键词 ： CA-125, 阵发性房颤, 持续性房颤, 心房重构

Abstract：Objective: To investigate the significance of CA-125 in patients with paroxysmal and persistent atrial fibrillation (AF). Methods: A retrospective study was made of 642 patients admitted to the First Affiliated Hospital of Wenzhou Medical University (China) from June 2017 to June 2018. All subjects enrolled were divided into two groups according to episode/persistent AF and they were compared in paroxysmal AF and persistent AF. Their clinical data (age, gender, BMI, duration of AF, left atrial diameter, ejection fraction, BNP, liver and kidney function, CHA2DS2-VASc score, CA-125, etc.) were analyzed to identify the risk factors of persistent AF by multivariate regression analysis. Results: Statistical regression results showed that patients with persistent AF had higher levels of CA-125 (P<0.001) compared with patients with paroxysmal AF. Logistic regression analyses showed that CA-125 levels appeared to be unaffected by age, LAD, ejection fraction, sex and so on. Conclusion: Patients with persistent AF have higher CA-125 level.

Key words： CA-125 paroxysmal atrial fibrillation persistent atrial fibrillation atrial remodeling

收稿日期: 2019-05-09

通讯作者: 黄周青，主任医师，Email：susiehzq@126.com。

作者简介: 陈晨（1987-），男，浙江温州人，住院医师。

链接本文:

https://xb.wmu.edu.cn/CN/10.3969/j.issn.2095-9400.2019.12.011 或 https://xb.wmu.edu.cn/CN/Y2019/V49/I12/910

[1] CHUGH S S, HAVMOELLER R, NARAYANAN K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study[J]. Circulation, 2014, 129(8): 837-847.
[2] BALL J, CARRINGTON M J, MCMURRAY J J, et al. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century[J]. Int J Cardiol, 2013, 167(5): 1807-1824.
[3] JALIFE J, KAUR K. Atrial remodeling, fibrosis, and atrial fibrillation[J]. Trends Cardiovasc Med, 2015, 25(6): 475-484.
[4] ROLDÁN V, MARÍN F, MARTÍNEZ J G, et al. Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation[J]. Am J Cardiol, 2005, 95(7): 881-882.
[5] BARBIERI R L, NILOFF J M, BAST R C, et al. Elevated serum concentrations of CA-125 in patients with advanced endometriosis[J]. Fertil Steril, 1986, 45(5): 630-634.
[6] BIDART J M, THUILLIER F, AUGEREAU C, et al. Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring[J]. Clin Chem, 1999, 45(10): 1695-1707.
[7] HUNG C L, HUNG T C, LIU C C, et al. Relation of carbohydrate antigen-125 to left atrial remodeling and its prognostic usefulness in patients with heart failure and preserved left ventricular ejection fraction in women[J]. Am J Cardiol, 2012, 110(7): 993-1000.
[8] SEKIGUCHI H, SHIMAMOTO K, TAKANO M, et al. Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women[J]. Heart, 2016, 103(17): 1368-1373.
[9] 黄从新, 张澍, 黄德嘉, 等. 心房颤动: 目前的认识和治疗建议(2018)[J]. 中华心律失常学杂志, 2018, 22(4): 279-346.
[10] HOLDENRIEDER S, MOLINA R, GION M, et al. Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access OV Monitor assay on the UniCel Dxl 800 Immunoassay System[J]. Clin Chem Lab Med, 2008, 46(5): 588-599.
[11] YAGMUR E, DRIESCH R, GRESSNER A M, et al. Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay[J]. Clin Chem Lab Med, 2006, 44(4): 420-422.
[12] Casaclang-Verzosa G, Gersh B J, Tsang T S. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation[J]. J Am Coll Cardiol, 2008, 51(1): 1-11.
[13] NATTEL S, BURSTEIN B, DOBREV D. Atrial remodeling and atrial fibrillation: mechanisms and implications[J]. Circ Arrhythm Electrophysiol, 2008, 1(1): 62-73.
[14] NATTEL S, HARADA M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives[J]. J Am Coll Cardiol, 2014, 63(22): 2335-2345.
[15] THOMAS L, ABHAYARATNA W P. Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance [J]. JACC Cardiovasc Imaging, 2017, 10(1): 65-77.
[16] O’BRIEN T J, TANIMOTO H, KONISHI I, et al. More than 15 years of CA 125: what is known about the antigen, its structure and its function[J]. Int J Biol Markers, 1998, 13(4): 188-195.
[17] ZEILLEMAKER A M, VERBRUGH H A, HOYNCK VAN PAPENDRECHT A A, et al. CA 125 secretion by peritoneal mesothelial cells[J]. J Clin Path, 1994, 47(3): 263-265.
[18] NÚÑEZ J, NÚÑEZ E, CONSUEGRA L, et al. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?[J]. Heart, 2007, 93(6): 716-721.
[19] NÚÑEZ J, SANCHIS J, BODÍ V, et al. Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure[J]. Eur Heart J, 2010, 31(14): 1752-1763.
[20] D’ALOIA A, FAGGIANO P, AURIGEMMA G, et al. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure[J]. J Am Coll Cardiol, 2003, 41(10): 1805-1811.
[21] YUCEL H, KAYA H, ZORLU A, et al. Cancer antigen 125 levels and increased risk of new-onset atrial fibrillation[J]. Herz, 2014, 40 Suppl 2: 119-124.
[22] STANCIU A E, STANCIU M M, VATASESCU R G. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure[J]. Cytokine, 2018, 111: 13-11119.
[23] HARADA M, VAN WAGONER D R, NATTEL S. Role of inflammation in atrial fibrillation pathophysiology and man-agement[J]. Circ J, 2015, 79(3): 495-502.
[24] 郑建雷, 严沛元, 王海清. 非瓣膜性心房颤动与脑梗死的相关因素分析[J]. 温州医科大学学报, 2014, 44(1): 44-47.
[25] BULLER R E, BERMAN M L, BLOSS J D, et al. CA 125 regression: a model for epithelial ovarian cancer response[J]. Am J Obstet Gynecol, 1991, 165(2): 360-367.